Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US-11986446-B2 · May 21, 2024 · US
This page is not indexed by search engines while we improve data quality.
Jazz Pharmaceuticals Ireland Ltd — Physics
Jazz Pharmaceuticals Ireland Ltd holds 15 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Jazz Pharmaceuticals Ireland Ltd |
| Technology | Physics |
| Patents in slice | 15 |
| Recent patents in slice | 2 |
| First year | 2015 |
| Last year | 2024 |
Representative patents
Notable publications linking Jazz Pharmaceuticals Ireland Ltd to Physics.
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-2023190784-A1 · Jun 22, 2023 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-2023190784-A1 · Jun 22, 2023 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-2023190784-A1 · Jun 22, 2023 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-11571440-B2 · Feb 7, 2023 · US
Recent filings
Latest patents from Jazz Pharmaceuticals Ireland Ltd in Physics.
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
US-11986446-B2 · May 21, 2024 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-2023190784-A1 · Jun 22, 2023 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-2023190784-A1 · Jun 22, 2023 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-2023190784-A1 · Jun 22, 2023 · US
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US-11571440-B2 · Feb 7, 2023 · US
Related pages
Navigate to parent entity pages.